Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Geron Corp (NQ: GERN )

4.665 +0.065 (+1.41%)
Streaming Delayed Price Updated: 10:38 AM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 838,195
Open 4.660
Bid (Size) 4.660 (23)
Ask (Size) 4.670 (60)
Prev. Close 4.600
Today's Range 4.603 - 4.710
52wk Range 1.680 - 5.340
Shares Outstanding 508,766,846
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Geron to Announce Second Quarter 2024 Financial Results on August 8, 2024
From Geron Corporation
Via Business Wire
3 Under-$10 Biotech Stocks That Could Make You Rich
Discover three under-$10 biotech stocks with potential to make you rich with huge returns on investment through an in-depth analysis. 
Via InvestorPlace

Performance

YTD
+117.99%
+117.99%
1 Month
+0.32%
+0.32%
3 Month
+25.07%
+25.07%
6 Month
+128.68%
+128.68%
1 Year
+53.96%
+53.96%

More News

Read More
3 Longevity Stocks to Buy for Anti-Aging Breakthroughs
Via InvestorPlace
Trading SMID Biotech Stocks In A Volatile Market
Via Talk Markets
Critical Insights From Geron Analyst Ratings: What You Need To Know
Via Benzinga
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
How to Invest in Penny Stocks in 2024: 3 Best Picks
Via InvestorPlace
3 Penny Stocks to Buy if You Want to Spend Less and Earn More
Via InvestorPlace
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
ICC Holdings, Diamond Offshore Drilling, CrowdStrike And Other Big Stocks Moving Higher On Monday
Via Benzinga
Is Geron Stock a Buy Following Its First New Drug Approval?
Via The Motley Fool
Crude Oil Edges Lower; Asensus Surgical Shares Jump
Via Benzinga
Exposures Fossil Fuels
Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Geron Corporation: FDA Approval Fuels Stock Price Surge
Via MarketBeat
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Gold Falls Sharply; Geron Shares Spike Higher
Via Benzinga
FDA Reverses Juul Ban. What Comes Next?
Via InvestorPlace
Exposures Product Safety
Why Is Geron (GERN) Stock Up 18% Today?
Via InvestorPlace
Exposures Product Safety
Argan Reports Strong Earnings, Joins Geron, Planet Labs PBC And Other Big Stocks Moving Higher On Friday
Via Benzinga
FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why Braze Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia
From Geron Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.